Related Experiment Video
Updated: Jun 12, 2025
07:34
Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
12.7K
Inclusion of dilution quality control samples in quantitative LC-MS bioanalysis
Wenkui Li1, Yunlin Fu1, Franck Picard2
1Pharmacokinetic Sciences, Novartis Biomedical Research, East Hanover, NJ 07936, USA.
Bioanalysis
|September 26, 2024
Summary
Sample dilution in LC-MS bioanalysis ensures accurate results by managing analyte concentrations and reducing matrix effects. Following good practices and demonstrating dilution integrity are crucial for reliable bioanalytical data.
Area of Science:
- Analytical Chemistry
- Pharmacokinetics
- Biotechnology
Background:
- Liquid Chromatography-Mass Spectrometry (LC-MS) is a key technique in bioanalysis.
- Sample dilution is often necessary to quantify analytes within the dynamic range of the assay.
- Matrix effects can interfere with accurate analyte measurement in biological samples.
Discussion:
- Dilution is critical for managing analyte concentrations and mitigating matrix effects in LC-MS bioanalysis.
- Adherence to regulatory guidelines for sample preparation is essential.
- Demonstrating dilution integrity is a mandatory step in validating bioanalytical methods.
Key Insights:
- Proper sample dilution ensures analyte concentrations fall within the validated dynamic range.
- Dilution can effectively alleviate matrix effects, improving accuracy and precision.
- Dilution integrity must be proven for all diluted samples within an analytical run.
Outlook:
- Standardized good dilution practices will enhance the reliability of bioanalytical studies.
- Future research may focus on automated dilution strategies for high-throughput bioanalysis.
- Continued emphasis on regulatory compliance ensures the integrity of drug development data.
